Thе role of zinc in the development of cardiovascular complications in patients with Graves’ disease

Backgraund. The development of cardiovascular complications in patients with diffuse-toxic goiter (DTZ) is an actual problem of thyroidology. (SSS) in patients with DTZ.

Aims. To assess the contribution of zinc deficiency in the formation of cardiovascular complications in patients with Graves’ disease.

Methods. The study included 113 women aged 25–60 years with the diagnosis of DTZ: 54.0% (n = 61) with an average severity of thyrotoxicosis, 46.0% (n = 52) with severe. Duration of the disease is 1–5 years. The control group consisted of 37 women aged 25–60 years without pathology of the thyroid gland and CCC. All patients were evaluated: in the blood – the level of thyroid-stimulating hormone (TTG), free thyroxine (over T4), the concentration of antibodies to the thyroid-stimulating hormone receptor (AT to RTTG); in the hair – the concentration of zinc; ultrasound (ultrasound) of the thyroid gland, echocardiography (EchoCG), daily monitoring of electrocardiography (CM ECG).

Results. At DTZ deficiency of zinc in hair was observed in 66.4% (n = 75), in the control group – in 27.0% (n = 10) patients (p = 0.01). More often, zinc deficiency was found at a severe degree of DTZ in 82.7% (n = 43), atrial fibrillation (AF) in 77.4% (n = 24) cases, in CHF – 78.8% (n = 41) cases. The diagnostic model and the table of risk factors of CHF in points, including the definition of the level of zinc in the hair, are developed with the help of logistic regression. It is advisable to use the table for all patients with DTZ to determine the degree of CHF risk, with an average and high risk of developing CHF in the treatment of DTZ, it is shown to include zinc preparations.

Conclusion. The obtained data allow to consider that the zinc deficiency increases the probability of development of AF and CHF in patients with DTZ of severe severity, needs diagnostics and correction.

zinc, Graves’ disease, atrial fibrillation, chronic heart failure

1. Фролова А.В., Родионова Т.И. Роль цитокинов в развитии поражения сердечно-сосудистой системы при диффузно-токсическом зобе. // Фундаментальные исследования. – 2014. – №7-2. – С. 412–418. [Frolova AV, Rodionova TI. The role of cytocines in patogenesis of cardiovascular system damage in Graves’ disease. Fundamental research. 2014;(7-2):412-418. (In Russ.)]

2. Какчекеева Т.Т., Салиева Б.Р., Логачева Е.Г., и др. Результаты хирургического лечения диффузно-токсического зоба (болезни Грейвса). // Вестник Кыргызско-российского Славянского университета. – 2013. – Т. 13. – №1. – С. 114–117. [Kakchekeeva TT, Salieva BR, Logacheva EG, et al. Results of surgical treatment of patients with diffuse toxic goiter (Graves’ disease). Vestnik Kyrgyzsko-rossiyskogo Slavyanskogo universiteta. 2013; 13(1):114-117. (In Russ.)]

3. Шульгина В.Ю., Фадеев В.В., Мельниченко Г.А. Поражение миокарда при тиреотоксикозе: особенности течения, исходы, отдаленный прогноз. // Клиническая и экспериментальная тиреоидология. – 2006. – Т. 2. – №4. – С. 21–30. [Shulgina VY, Fadeyev VV, MelnichenkoGA. Myocardial lesion in hyperthyroidism: natural history, outcomes, prognosis. Clinical and experimental thyroidology. 2006;2(4):21-30. (In Russ.)] doi: 10.14341/ket20062421-30.

4. Фархутдинова Л.М., Бруй А.Л. Возрастные особенности диффузно-токсического зоба. Случай из практики. // Архивъ внутренней медицины. – 2015. – №3. – С. 40–44. [Farkhutdinova LM, Bruj AL. Vozrastnye osobennosti diffuzno-toksicheskogo zoba. Sluchay iz praktiki. Archive of internal medicine. 2015;(3): 40-44. (In Russ.)] doi: 10.20514/2226-6704-2015-0-3-40-44.

5. Авцын А.П., Жаворонков А.А. Микроэлементозы человека. – М.: Медицина; 1991. [Avtsyn AP, Zhavoronkov AA. Mikroelementozy cheloveka. Moscow: Meditsina; 1991. (In Russ.)]

6. Alexanian I, Parissis J, Farmakis D, et al. Clinical and echocardiographic correlates of serum copper and zinc in acute and chronic heart failure. Clin Res Cardiol. 2014;103(11):938-949. doi: 10.1007/s00392-014-0735-x.

7. Трошина Е.А., Свириденко Н.Ю., Ванушко В.Э., и др. Федеральные клинические рекомендации по диагностике и лечению тиреотоксикоза с диффузным зобом. // Проблемы эндокринологии. – 2014. – Т. 60. – №6. – С. 67–77. [Troshina EA, Sviridenko NY, Vanushko VE, et al. The federal clinical recommendations on diagnostics and treatment of toxic goiter. Problems of endocrinology. 2014;60(6):67-77. (In Russ.)] doi: 10.14341/probl201460667-77.

8. Фефилова И.Б. Антивозрастная медицина. Современная энциклопедия. – М.: Эксмо; 2015. [Fefilova IB Antivozrastnaya meditsina. Sovremennaya entsiklopediya. Moscow: Eksmo; 2015. (In Russ.)]

9. Gutekunst R, Martin-Teichert H. Requirements for goiter surveys and the determination of thyroid size. In: Delange F, Dunn JT, Glinoer D, editors. Iodine Deficiency in Europe. A Continuing Concern. Boston: Springer; 1993. p. 109-118. doi: 10.1007/978-1-4899-1245-9_12.

10. Лисицын Е.П. Общественное здоровье и здравоохранение: Учебник. – М.: ГЭОТАР-МЕД; 2002. [Lisitsyn EP. Obshchestvennoe zdorov’e i zdravookhranenie. Tutorial. Moscow: GEOTAR-MED; 2002. (In Russ.)]

11. Кудрин А.В., Громова О.А. Микроэлементы в онкологии и иммунологии. – М.: ГЭОТАР; 2007. [Kudrin AV, Gromova OA. Mikroelementy v onkologii i immunologii. Moscow: GEOTAR; 2007. (In Russ.)]

12. McKeag NA, McKinley MC, Woodside JV, et al. The role of micronutrients in heart failure. J Acad Nutr Diet. 2012;112(6): 870-886. doi: 10.1016/j.jand.2012.01.016.

13. Ertek S, Cicero A, Caglar O, Erdogan G. Relationship between serum zinc levels, thyroid hormones and thyroid volume following successful iodine supplementation. Hormones (Athens). 2010; 9(3):263-268. doi: 10.14310/horm.2002.1276.

14. Napolitano G, Palka G, Lio S, et al. Is zinc deficiency a cause of subclinical hypothyroidism in Down syndrome? Ann Genet. 1990;33(1):9-15.

15. Maxwell C, Volpe SL. Effect of zinc supplementation on thyroid hormone function. A case study of two college females. Ann Nutr Metab. 2007;51(2):188-194. doi: 10.1159/000103324.

16. Bacic-Vrca V, Skreb F, Cepelak I, et al. The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves’ disease. Clin Chem Lab Med. 2005;43(4):383-388. doi: 10.1515/CCLM.2005.069.

17. Haase H, Rink L. Multiple impacts of zinc on immune function. Metallomics. 2014;6(7):1175-1180. doi: 10.1039/c3mt00353a.

18. Виниченко Д.С., Квиткова Л.В., Зинчук С.Ф., Коростелев А.А. О взаимосвязи развития диффузно-токсического зоба тяжелой и средней степени тяжести с обеспеченностью организма цинком. // Врач-аспирант. – 2016. – Т. 76. – №3. – С. 71–80. [Vinichenko DS, KvitkovaLV, Zinchuk SF, Korostelev AA. On the relationship between the development of diffuse-toxic goiter of severe and moderate severity with the security body’s zinc. Vrach-aspirant. 2016;76(3):71-80. (In Russ.)]

19. Казмирчук В.Е., Ковальчук Л.В., Мальцев Д.В. Клиническая иммунология и аллергология с возрастными особенностями. – Киев: Медицина; 2012. [Kazmurchuk VE, Kovalchuk LV, Maltsev DV. Klinicheskaya immunologiya i allergologiya s vozrastnymi osobennostyami. Kiev: Meditsina; 2012. (In Russ.)]

20. Ghaemian A, Salehifar E, Jalalian R, et al. Zinc and copper levels in severe heart failure and the effects of atrial fibrillation on the zinc and copper status. Biol Trace Elem Res. 2011;143(3):1239-1246. doi: 10.1007/s12011-011-8956-6.